T-5224 是一种选择性的 c-Fos/JunD 异二聚体抑制剂,对 AP-1 的 IC50 值为 5 μM。T-5224 具有抗炎和抗肿瘤作用,可用于炎症性疾病和癌症的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50μL*10mM(DMSO) | ¥129随货¥99 | 咨询 | |
100μL*10mM(DMSO) | ¥189 | 咨询 | |
250μL*10mM(DMSO) | ¥369 | 咨询 | |
500μL*10mM(DMSO) | ¥569 | 咨询 | |
10mM*1mL(DMSO) | ¥876 | 咨询 | |
1mg | ¥286 | 咨询 | |
5mg | ¥693 | 咨询 | |
10mg | ¥1039 | 咨询 | |
25mg | ¥1969 | 咨询 | |
50mg | ¥2488 | 咨询 | |
100mg | ¥3748 | 咨询 | |
1g | ¥30907 | 咨询 |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | T-5224 serves as an inhibitor of the transcription factor c-Fos/activator protein (AP)-1, offering anti-inflammatory benefits by specifically targeting the DNA binding activity of c-Fos/c-Jun, while leaving other transcription factors unaffected. It effectively prevents the IL-1β-induced increase in the transcription of Mmp-3, Mmp-13, and Adamts-5[1][2]. |
体内研究 | After intraperitoneal injection of LPS, T-5224(300 mg/kg, orally) was taken. The results showed that the levels of TNFα, HMGB1, ALT/AST in serum and MIP-1α and MCP-1 in liver tissue increased sharply, which had obvious protective effect on mice and reduced the mortality rate (27%) [4]. G2, a primary metabolite of T-5224 in rat and monkey liver microsomes, is not exclusive to humans as a metabolite[5]. T-5224 (300 mg/kg, pO.) suppresses the synthesis of TNF-alpha and various downstream effectors in C57BL/6 mice[6]. |
体外研究 | T-5224 suppresses the in-vitro synthesis of mediators such as MMP-1, MMP-3, IL-6, and TNF-α in IL-1β-stimulated human synovial SW982 cells, with an average IC50 value of 10 μM[2]. T-5224 (0-80 μM) markedly inhibits the invasion, migration, and MMP activity of HSC-3-M3 cells in a dose-dependent manner[3]. |
计算器 | ||||
存储液制备 | ![]() | 1mg | 5mg | 10mg |
1 mM 5 mM 10 mM | 1.93mL 0.39mL 0.19mL | 9.66mL 1.93mL 0.97mL | 19.32mL 3.86mL 1.93mL |
CAS号 | 530141-72-1 |
分子式 | C29H27NO8 |
分子量 | 517.527 |
别名 | |
运输 | 蓝冰 |
存储条件 | In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere,2-8°C |
溶解方案 | DMSO: 105 mg/mL(202.89 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 | IP 2% DMSO+2% Tween80+30% PEG300+water 8 mg/mL clear PO 0.5% CMC-Na 31 mg/mL suspension |